Lineage Cell Therapeutics In shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $0 | 9.4k | 0.00 |
| 2023-09-30 | $0 | 8.8k | 0.00 |
| 2023-06-30 | $0 | 8.4k | 0.00 |
| 2023-03-31 | $0 | 8.1k | 0.00 |
| 2022-12-31 | $99k | 85k | 1.16 |
| 2022-09-30 | $88k | 78k | 1.13 |
| 2021-12-31 | $52k | 22k | 2.41 |